公司問答丨禾川科技:公司產品所用SOC/MCU芯片均是自主開發設計 目前已批量在公司產品中使用
格隆匯7月24日丨禾川科技(688320.SH)今日在互動平台表示,公司產品所用SOC/MCU芯片均是自主開發設計,委託國內芯片廠家封裝流片,目前均已批量在公司產品中使用。公司此前還透露,在人形機器人涉及的運動控制技術方面,公司在伺服驅動器軟件、總線通信技術、集成控制芯片、電機減速機一體集成傳動等方面有較深的前沿技術儲備;在人形機器人涉及的核心運動控制部件中,公司有較成熟的伺服電機、步進電機、空心杯電機、無框電機等各類電機及相關傳感器產品,其中伺服產品在國內有較高的市場佔有率,其他產品均有實現量產,但銷售佔比較少;滾珠絲桿有一定的研發技術積累,未批量化生產推向市場。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.